America’s largest legal cannabis companies are backing the formation of the U.S. Cannabis Roundtable, a new advocacy group taking aim at the logjam around marijuana reform on the federal level ...
Medical cannabis is legal in the UK. This means that in some circumstances, specialist doctors may prescribe it to treat epilepsy. On this page, we talk about the different types of medical cannabis ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
As two individuals whose lives have been deeply impacted by cannabis, we are encouraged by President Donald Trump’s recent statements supporting long-overdue reforms to U.S. cannabis policy.
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
House Bill 7 aims to amend an existing law that sets penalties for marijuana possession, now heads to the Senate. The bill passed the House Tuesday by a vote of 54 to 14. It adds a mandatory ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...